422 related articles for article (PubMed ID: 29427646)
1. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
[TBL] [Abstract][Full Text] [Related]
2. Uncovering the DNA methylome in chronic lymphocytic leukemia.
Cahill N; Rosenquist R
Epigenetics; 2013 Feb; 8(2):138-48. PubMed ID: 23321535
[TBL] [Abstract][Full Text] [Related]
3. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.
Baer C; Claus R; Frenzel LP; Zucknick M; Park YJ; Gu L; Weichenhan D; Fischer M; Pallasch CP; Herpel E; Rehli M; Byrd JC; Wendtner CM; Plass C
Cancer Res; 2012 Aug; 72(15):3775-85. PubMed ID: 22710432
[TBL] [Abstract][Full Text] [Related]
4. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic and genetic alterations and their influence on gene regulation in chronic lymphocytic leukemia.
Huang D; Ovcharenko I
BMC Genomics; 2017 Mar; 18(1):236. PubMed ID: 28302063
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
[TBL] [Abstract][Full Text] [Related]
7. Advances in epigenetic alterations of chronic lymphocytic leukemia: from pathogenesis to treatment.
Zhang X; Wang H; Zhang Y; Wang X
Clin Exp Med; 2024 Mar; 24(1):54. PubMed ID: 38492089
[TBL] [Abstract][Full Text] [Related]
8. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia.
Chen SS; Raval A; Johnson AJ; Hertlein E; Liu TH; Jin VX; Sherman MH; Liu SJ; Dawson DW; Williams KE; Lanasa M; Liyanarachchi S; Lin TS; Marcucci G; Pekarsky Y; Davuluri R; Croce CM; Guttridge DC; Teitell MA; Byrd JC; Plass C
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13433-8. PubMed ID: 19666576
[TBL] [Abstract][Full Text] [Related]
10. Altered DNA Methylation Profiles in
Pacholewska A; Grimm C; Herling CD; Lienhard M; Königs A; Timmermann B; Altmüller J; Mücke O; Reinhardt HC; Plass C; Herwig R; Hallek M; Schweiger MR
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502260
[TBL] [Abstract][Full Text] [Related]
11. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between DNA methylation and active histone modifications regulates aberrant expression of ZAP70 in CLL.
Amin S; Walsh M; Wilson C; Parker AE; Oscier D; Willmore E; Mann D; Mann J
J Cell Mol Med; 2012 Sep; 16(9):2074-84. PubMed ID: 22151263
[TBL] [Abstract][Full Text] [Related]
13. Gene expression and epigenetic deregulation.
Shaknovich R
Adv Exp Med Biol; 2013; 792():133-50. PubMed ID: 24014295
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Wang LQ; Chim CS
Epigenomics; 2015; 7(3):461-73. PubMed ID: 25650645
[TBL] [Abstract][Full Text] [Related]
15. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments.
Cahill N; Bergh AC; Kanduri M; Göransson-Kultima H; Mansouri L; Isaksson A; Ryan F; Smedby KE; Juliusson G; Sundström C; Rosén A; Rosenquist R
Leukemia; 2013 Jan; 27(1):150-8. PubMed ID: 22922567
[TBL] [Abstract][Full Text] [Related]
16. TWIST2 demonstrates differential methylation in immunoglobulin variable heavy chain mutated and unmutated chronic lymphocytic leukemia.
Raval A; Lucas DM; Matkovic JJ; Bennett KL; Liyanarachchi S; Young DC; Rassenti L; Kipps TJ; Grever MR; Byrd JC; Plass C
J Clin Oncol; 2005 Jun; 23(17):3877-85. PubMed ID: 15809452
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials.
Wojdacz TK; Amarasinghe HE; Kadalayil L; Beattie A; Forster J; Blakemore SJ; Parker H; Bryant D; Larrayoz M; Clifford R; Robbe P; Davis ZA; Else M; Howard DR; Stamatopoulos B; Steele AJ; Rosenquist R; Collins A; Pettitt AR; Hillmen P; Plass C; Schuh A; Catovsky D; Oscier DG; Rose-Zerilli MJJ; Oakes CC; Strefford JC
Blood Adv; 2019 Aug; 3(16):2474-2481. PubMed ID: 31434681
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.
Rodríguez-Vicente AE; Díaz MG; Hernández-Rivas JM
Cancer Genet; 2013 Mar; 206(3):49-62. PubMed ID: 23531595
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.
Wang LQ; Wong KY; Li ZH; Chim CS
Oncotarget; 2016 Dec; 7(50):82400-82410. PubMed ID: 27689399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
